Jonas Busch Selected Research

Nephrectomy

1/2020	[A retrospective analysis of functional and oncologic outcomes following surgical treatment of patients with pT1/pT2 renal cell carcinoma at a tertiary referral centre].
1/2019	Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer.
1/2019	Native T1 Mapping as an In Vivo Biomarker for the Identification of Higher-Grade Renal Cell Carcinoma: Correlation With Histopathological Findings.
9/2018	miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma.
6/2018	[The use of partial nephrectomy in the treatment of patients with pT1/pT2 renal cell carcinoma: a trend analysis from a tertiary referral centre].
5/2018	Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI.
4/2016	Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer.
1/2016	Long-Term Donor Outcomes after Pure Laparoscopic versus Open Living Donor Nephrectomy: Focus on Pregnancy Rates, Hypertension and Quality of Life.
6/2015	Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas.
2/2013	Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonas Busch Research Topics

Disease

25	Renal Cell Carcinoma (Grawitz Tumor) 12/2020 - 01/2011
19	Neoplasms (Cancer) 12/2020 - 05/2010
10	Prostatic Neoplasms (Prostate Cancer) 06/2020 - 01/2012
6	Neoplasm Metastasis (Metastasis) 12/2022 - 10/2011
3	Residual Neoplasm 12/2022 - 02/2012
3	Margins of Excision 11/2016 - 12/2012
2	Seminoma 12/2022 - 12/2022
2	Testicular Neoplasms (Testicular Cancer) 12/2022 - 05/2012
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2022 - 02/2012
2	Lymphatic Metastasis 12/2022 - 01/2012
2	Carcinogenesis 01/2016 - 05/2010
1	Human Influenza (Influenza) 12/2022
1	Hypersensitivity (Allergy) 10/2022
1	Sepsis (Septicemia) 10/2022
1	Infections 10/2022
1	Urinary Tract Infections (Urinary Tract Infection) 10/2022
1	Neoplasm Micrometastasis 12/2019
1	Cysts 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Thrombosis (Thrombus) 05/2018
1	Erectile Dysfunction 04/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Shock 04/2017
1	7 Hereditary Prostate Cancer 09/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Pneumonia (Pneumonitis) 08/2013
1	Thrombocytopenia (Thrombopenia) 05/2008
1	Critical Illness (Critically Ill) 05/2008
1	Heart Failure 05/2008
1	Heart Diseases (Heart Disease) 05/2008
1	Myocardial Infarction 01/2008
1	Ischemia 01/2008

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 06/2020 - 05/2010
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 12/2012
4	Tyrosine Kinase InhibitorsIBA 09/2018 - 01/2011
3	Biomarkers (Surrogate Marker)IBA 06/2020 - 01/2016
2	RNA (Ribonucleic Acid)IBA 12/2022 - 02/2020
2	Contrast MediaIBA 12/2022 - 11/2019
2	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 12/2022
2	Pharmaceutical PreparationsIBA 10/2022 - 09/2018
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2016
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2014 - 08/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2011 - 07/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2022
1	Ifosfamide FDA LinkGeneric 12/2022
1	ProteomeIBA 12/2020
1	Amino Acids FDA Link 12/2020
1	CollagenIBA 01/2019
1	AntigensIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Vitamin D FDA LinkGeneric 09/2016
1	25-hydroxyvitamin DIBA 09/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2016
1	Cell-Free Nucleic AcidsIBA 01/2016
1	Piwi-Interacting RNAIBA 06/2015
1	Everolimus FDA Link 08/2013
1	temsirolimus FDA Link 08/2013
1	CytokinesIBA 05/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012
1	Sunitinib (Sutent)FDA Link 01/2011
1	MTOR InhibitorsIBA 01/2011
1	Heparin (Liquaemin)FDA LinkGeneric 05/2008

Therapy/Procedure

11	Therapeutics 12/2022 - 05/2010
11	Prostatectomy (Retropubic Prostatectomy) 06/2020 - 12/2012
10	Nephrectomy 01/2020 - 02/2013
4	Drug Therapy (Chemotherapy) 12/2022 - 02/2012
4	Lymph Node Excision (Lymph Node Dissection) 12/2019 - 01/2012
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2008 - 01/2008
1	Salvage Therapy 12/2022
1	Antibiotic Prophylaxis 10/2022
1	Thrombectomy 05/2018
1	Penile Prosthesis (Penile Implants) 04/2018
1	Conservative Treatment 04/2018
1	Cystectomy 01/2018
1	Percutaneous Nephrolithotomy 04/2017
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 04/2017
1	Indwelling Catheters (Indwelling Catheter) 01/2017
1	Operative Time 01/2017
1	Radiotherapy 11/2014
1	Operative Surgical Procedures 02/2012
1	Prostheses and Implants (Prosthesis) 02/2012
1	Combined Modality Therapy 02/2012
1	Castration 01/2012
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 05/2008
1	Heart-Assist Devices 05/2008
1	Sternotomy 05/2008
1	Cannula 01/2008